|Titre :||The adverse consequences of mephedrone use: a case series (2011)|
|Auteurs :||K. MACKAY ; M. TAYLOR ; N. BAJAJ|
|Type de document :||Article : Périodique|
|Dans :||Psychiatrist (The) (Vol.35, n°6, June 2011)|
|Article en page(s) :||203-205|
|Discipline :||PRO (Produits, mode d'action, méthode de dépistage / Substances, action mode, screening methods)|
Thésaurus TOXIBASEMEPHEDRONE ; ETUDE DE CAS ; EFFET SECONDAIRE ; SYMPTOME ; DROGUES DE SYNTHESE ; URGENCE
Aims and method: Mephedrone is a cathinone with amphetamine-like stimulant effects, and is a commonly used recreational drug. The adverse effects of mephedrone use have not been extensively studied. All individuals who self-presented between January and June 2010 to the emergency departments and acute mental health services in Edinburgh and Falkirk with adverse effects of self-reported mephedrone use were identified.
Results: Twenty cases were identified and analysed. Severe agitation was the most common presenting problem (70%), with 40% of individuals developing psychotic symptoms and a further 20% reporting low mood and suicidality. One person died by suicide.
Clinical implications: Mephedrone can produce amphetamine-like adverse psychological intoxication effects, particularly in those with a history of mental illness. Clinicians should consider advising patients on the adverse effects of mephedrone, where relevant.
|Domaine :||Drogues illicites / Illicit drugs|
|Sous-type de document :||Etude de cas / Case report|
|Refs biblio. :||12|
|Affiliation :||NHS Lothian; NHS Greater Glasgow and Clyde, UK|